$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

$jazz Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000123252415000157 Filed on November 09, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$340.9M	$340.9M	$306.6M
YoY Change	3.88%	11.18%	32.06%
Cost Of Revenue	$24.00M	$28.40M	$27.00M
YoY Change	-16.67%	5.19%	11.11%
Gross Profit	$314.9M	$310.4M	$277.4M
YoY Change	6.59%	11.88%	34.58%
Gross Profit Margin	92.38%	91.05%	90.49%
Selling, General & Admin	$124.3M	$104.0M	$93.50M
YoY Change	19.75%	11.28%	24.72%
% of Gross Profit	39.47%	33.52%	33.7%
Research & Development	$29.50M	$50.78M	$22.42M
YoY Change	4816.67%	126.48%	89.61%
% of Gross Profit	9.37%	16.36%	8.08%
Depreciation & Amortization	$26.50M	$28.70M	$32.40M
YoY Change	-22.29%	-11.42%	58.82%
% of Gross Profit	8.42%	9.25%	11.68%
Operating Expenses	$177.5M	$209.3M	$248.5M
YoY Change	29483.33%	-15.77%	88.87%
Operating Profit	$137.4M	$131.5M	$58.04M
YoY Change	-53.4%	126.64%	-42.29%
Interest Expense	-$10.10M	-$12.65M	-$14.53M
YoY Change	-31.29%	-12.94%	134.28%
% of Operating Profit	-7.35%	-9.62%	-25.04%
Other Income/Expense, Net		-$977.0K
YoY Change
Pretax Income	$96.50M	$117.9M	$49.99M
YoY Change	-16.23%	135.86%	-46.67%
Income Tax	$13.70M	$29.95M	$24.22M
% Of Pretax Income	14.2%	25.4%	48.45%
Net Earnings	$82.76M	$87.96M	$25.77M
YoY Change	1.41%	241.38%	-65.83%
Net Earnings / Revenue	24.28%	25.8%	8.4%
Basic Earnings Per Share	$1.35	$1.43	$0.43
Diluted Earnings Per Share	$1.32	$1.39	$0.41
COMMON SHARES
Basic Shares Outstanding	61.50M shares	61.44M shares	60.31M shares
Diluted Shares Outstanding		63.15M shares	62.68M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$988.8M	$998.9M	$575.0M
YoY Change	44.56%	73.72%	-2.29%
Cash & Equivalents	$988.8M	$998.9M	$575.0M
Short-Term Investments	$0.00	$999.0M	$575.0M
Other Short-Term Assets	$19.05M	$18.97M	$18.36M
YoY Change	-10.67%	3.31%	-1.02%
Inventory	$19.45M	$30.02M	$37.61M
Prepaid Expenses	$20.70M	$21.28M	$24.21M
Receivables	$209.7M	$195.8M	$187.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.258B	$1.315B	$878.5M
YoY Change	23.81%	49.68%	8.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$85.57M	$83.45M	$44.21M
YoY Change	46.62%	88.78%	266.54%
Goodwill	$657.1M	$669.0M	$724.4M
YoY Change	-6.49%	-7.64%	62.12%
Intangibles	$1.186B	$1.271B	$1.551B
YoY Change	-17.52%	-18.05%	88.25%
Long-Term Investments
YoY Change
Other Assets	$9.271M	$25.39M	$13.48M
YoY Change	-41.81%	88.35%	110.95%
Total Long-Term Assets	$2.075B	$2.149B	$2.469B
YoY Change	-10.68%	-12.95%	79.51%
TOTAL ASSETS
Total Short-Term Assets	$1.258B	$1.315B	$878.5M
Total Long-Term Assets	$2.075B	$2.149B	$2.469B
Total Assets	$3.333B	$3.464B	$3.348B
YoY Change	-0.19%	3.49%	53.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.81M	$29.12M	$29.67M
YoY Change	-13.21%	-1.84%	32.26%
Accrued Expenses	$164.1M	$166.4M	$161.5M
YoY Change	-0.01%	3.03%	51.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$37.59M	$117.6M	$9.444M
YoY Change	298.67%	1145.12%	69.49%
Total Short-Term Liabilities	$226.6M	$340.2M	$223.7M
YoY Change	4.54%	52.05%	10.02%
LONG-TERM LIABILITIES
Long-Term Debt	$1.151B	$1.172B	$1.331B
YoY Change	-13.66%	-11.96%	144.03%
Other Long-Term Liabilities	$69.25M	$59.67M	$33.60M
YoY Change	80.38%	77.6%	100.61%
Total Long-Term Liabilities	$1.220B	$1.232B	$1.365B
YoY Change	-11.03%	-9.76%	142.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$226.6M	$340.2M	$223.7M
Total Long-Term Liabilities	$1.220B	$1.232B	$1.365B
Total Liabilities	$1.447B	$1.572B	$1.589B
YoY Change	-8.91%	-1.05%	107.49%
SHAREHOLDERS EQUITY
Retained Earnings	$302.7M	$260.2M	-$34.67M
YoY Change	772.19%	-850.52%	1196.41%
Common Stock	$1.563B	$1.534B	$1.432B
YoY Change	7.19%	7.14%	19.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.706B	$1.563B	$1.341B
YoY Change
Total Liabilities & Shareholders Equity	$3.333B	$3.464B	$3.348B
YoY Change	-0.19%	3.49%	53.17%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$82.76M	$87.96M	$25.77M
YoY Change	1.41%	241.38%	-65.83%
Depreciation, Depletion And Amortization	$26.50M	$28.70M	$32.40M
YoY Change	-22.29%	-11.42%	58.82%
Cash From Operating Activities	$119.7M	$175.1M	$129.7M
YoY Change	-10.87%	35.0%	-0.84%
INVESTING ACTIVITIES
Capital Expenditures	-$3.400M	-$5.200M	-$83.10M
YoY Change	-76.06%	-93.74%	2496.88%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$3.400M	-$5.200M	-$83.20M
YoY Change	-75.89%	-93.75%	2500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-123.8M	-94.50M	263.3M
YoY Change	1079.05%	-135.89%	-676.15%
NET CHANGE
Cash From Operating Activities	119.7M	175.1M	129.7M
Cash From Investing Activities	-3.400M	-5.200M	-83.20M
Cash From Financing Activities	-123.8M	-94.50M	263.3M
Net Change In Cash	-7.500M	75.40M	309.8M
YoY Change	-106.84%	-75.66%	278.27%
FREE CASH FLOW
Cash From Operating Activities	$119.7M	$175.1M	$129.7M
Capital Expenditures	-$3.400M	-$5.200M	-$83.10M
Free Cash Flow	$123.1M	$180.3M	$212.8M
YoY Change	-17.1%	-15.27%	58.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001232524
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61497753	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Jazz Pharmaceuticals plc
	dei	Trading Symbol TradingSymbol	JAZZ
CY2014Q4	jazz	Accrued Construction In Progress AccruedConstructionInProgress	4931000	USD
CY2015Q3	jazz	Accrued Construction In Progress AccruedConstructionInProgress	1690000	USD
CY2014Q4	jazz	Accrued Interest AccruedInterest	10327000	USD
CY2015Q3	jazz	Accrued Interest AccruedInterest	1927000	USD
CY2014Q4	jazz	Accrued Milestone Payments AccruedMilestonePayments	0	USD
CY2015Q3	jazz	Accrued Milestone Payments AccruedMilestonePayments	25000000	USD
CY2014Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	51899000	USD
CY2015Q3	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	63676000	USD
CY2014Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	471000	USD
CY2015Q3	jazz	Capital Redemption Reserve CapitalRedemptionReserve	471000	USD
CY2014Q4	jazz	Computer Equipment Gross ComputerEquipmentGross	7670000	USD
CY2015Q3	jazz	Computer Equipment Gross ComputerEquipmentGross	11266000	USD
CY2014Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	26994000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	88610000	USD
CY2015Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	28385000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	78496000	USD
CY2014Q4	jazz	Entity Wide Accounts Receivable Major Customer Percentage EntityWideAccountsReceivableMajorCustomerPercentage	0.86
CY2015Q3	jazz	Entity Wide Accounts Receivable Major Customer Percentage EntityWideAccountsReceivableMajorCustomerPercentage	0.88
	jazz	Fair Value Inventory Step Up Adjustment FairValueInventoryStepUpAdjustment	10477000	USD
	jazz	Fair Value Inventory Step Up Adjustment FairValueInventoryStepUpAdjustment	0	USD
CY2014Q3	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
CY2015Q3	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	-16815000	USD
	jazz	Increase Decreasein Contingent Consideration IncreaseDecreaseinContingentConsideration	-14900000	USD
	jazz	Increase Decreasein Contingent Consideration IncreaseDecreaseinContingentConsideration	0	USD
CY2014Q4	jazz	Landand Buildings Gross LandandBuildingsGross	1547000	USD
CY2015Q3	jazz	Landand Buildings Gross LandandBuildingsGross	1775000	USD
	jazz	Loss Contingency Radiopharmaceutical Products Number LossContingencyRadiopharmaceuticalProductsNumber	2	product
CY2014Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2015Q3	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2014Q4	jazz	Number Of Customers With Significant Accounts Receivable Balance NumberOfCustomersWithSignificantAccountsReceivableBalance	5	Customer
CY2015Q3	jazz	Number Of Customers With Significant Accounts Receivable Balance NumberOfCustomersWithSignificantAccountsReceivableBalance	5	Customer
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	202000000	USD
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7603000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	jazz	Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants	48452000	USD
	jazz	Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants	34025000	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	2873000	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	4021000	USD
CY2014Q3	jazz	Royalties And Contract Revenues RoyaltiesAndContractRevenues	2177000	USD
	jazz	Royalties And Contract Revenues RoyaltiesAndContractRevenues	6240000	USD
CY2015Q3	jazz	Royalties And Contract Revenues RoyaltiesAndContractRevenues	2118000	USD
	jazz	Royalties And Contract Revenues RoyaltiesAndContractRevenues	6027000	USD
CY2014Q4	jazz	Sales Return Reserve SalesReturnReserve	14039000	USD
CY2015Q3	jazz	Sales Return Reserve SalesReturnReserve	7757000	USD
	jazz	Stock Issued During Period Employee Plansand Warrants Exercises StockIssuedDuringPeriodEmployeePlansandWarrantsExercises	48452000	USD
	jazz	Stock Issued During Period Employee Plansand Warrants Exercises StockIssuedDuringPeriodEmployeePlansandWarrantsExercises	34025000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	25126000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	29124000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	186371000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	195816000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	46143000	USD
CY2015Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	33893000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	164091000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	166375000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3295000	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3808000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	7964000	USD
CY2015Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	5340000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15192000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21683000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-122097000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-231277000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1458005000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1534032000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	126862000	USD
	us-gaap	Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation	17306000	USD
	us-gaap	Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation	25402000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50919000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67729000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	4075000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	-320000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18251000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50618000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23114000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67233000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	12782000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	35447000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	16456000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	47511000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	17348000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30630000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	94607000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26127000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74472000	USD
CY2014Q4	us-gaap	Assets Assets	3338955000	USD
CY2015Q3	us-gaap	Assets Assets	3464300000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	1015845000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	1314943000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	32833000	USD
CY2015Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	684042000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	998859000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	684042000	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	998859000	USD
CY2014Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	10634000	USD
CY2015Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	14050000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	636504000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	575040000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	684042000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	998859000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-61464000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	314817000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91313000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-136511000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	104725000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	137594000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-8000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1067000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	14000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-91321000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-137578000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	104739000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	137599000	USD
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	37145000	USD
CY2015Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	61061000	USD
CY2015Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1405550000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	33174000	USD
CY2015Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	24315000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-36246000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25368000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1138000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1330000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4499000	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3646000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	48440000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	50006000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	75494000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	76391000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	9430000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	9417000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	375054000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	325216000	USD
	us-gaap	Depreciation Depreciation	5037000	USD
	us-gaap	Depreciation Depreciation	7143000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.04
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.91
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-2807000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-8035000	USD
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.273
CY2014Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5469000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	15171000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6658000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	19722000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4075000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-320000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4075000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-320000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	265845000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	313961000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	663429000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	24172000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	89399000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	89623000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	92510000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	92510000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1466532000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1365604000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1200687000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1051643000	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2220000	USD
CY2015Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2339000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-117000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	702713000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	669029000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-33684000	USD
CY2014Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	32806000	USD
CY2015Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	49989000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36313000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	117905000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	339424000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24221000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60598000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29945000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92651000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-33865000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4826000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	50690000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10661000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	19003000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	8993000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19468000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4642000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-918000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-659000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10184000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3595000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5775000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	9555000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	12910000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	18469000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4262000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5298000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	87000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2288000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1719000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1927000	shares
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1703280000	USD
CY2015Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1584738000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1437435000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1270777000	USD
CY2014Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-14530000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-36035000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-12650000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-44707000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16597000	USD
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13994000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	30037000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	30018000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3570000	USD
CY2015Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3437000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9870000	USD
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12587000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	7931000	USD
CY2015Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8782000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3338955000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3464300000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	216801000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	340192000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	1342428000	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	1289692000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9428000	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	117589000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1175454000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	79792000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	61037000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	42280000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	37590000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	9397000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1333000000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1172103000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6408000	USD
CY2015Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5862000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	64000	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	14000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	136950000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	60000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	721474000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-90462000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1053475000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1112000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	273344000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	412202000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	25766000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23225000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	87960000	USD
	us-gaap	Net Income Loss NetIncomeLoss	246774000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1060000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	136578000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	248548000	USD
	us-gaap	Operating Expenses OperatingExpenses	779065000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	209340000	USD
	us-gaap	Operating Expenses OperatingExpenses	582330000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	58036000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	65668000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	131532000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	401592000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	115660000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	7197000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8054000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	12556000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	11683000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	73296000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2874000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25493000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23284000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	21322000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	18969000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15931000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25393000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-113293000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-109174000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-117089000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-113293000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16779000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-109174000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-117089000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113293000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	16779000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-109174000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38393000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	59666000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7382000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3834000	USD
CY2014Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6483000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6680000	USD
CY2015Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-977000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-646000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	35100000	USD
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	0	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	22799000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	32591000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	29973000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21302000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	2494000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17306000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	25402000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	136950000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	60000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	828676000	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	12800000	USD
CY2015Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21275000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	33703000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1195366000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	898960000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	25768000	USD
	us-gaap	Profit Loss ProfitLoss	-24285000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	87960000	USD
	us-gaap	Profit Loss ProfitLoss	246773000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73555000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105135000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58363000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83452000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	300000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	80000000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	7090000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	896363000	USD
CY2014Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	75000000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	202000000	USD
CY2015Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22423000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60622000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50784000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	105798000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34704000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	260176000	USD
CY2014Q3	us-gaap	Revenues Revenues	306584000	USD
	us-gaap	Revenues Revenues	844733000	USD
CY2015Q3	us-gaap	Revenues Revenues	340872000	USD
	us-gaap	Revenues Revenues	983922000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	304407000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	838493000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	338754000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104044000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93501000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	300420000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	977895000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	323564000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	50618000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	67233000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	29973000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21302000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1371144000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	1563463000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1295534000	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1340613000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1371208000	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1563477000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	7588000	USD
CY2015Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	16357000	USD
CY2015Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	25600000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62680000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59457000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63154000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63072000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60305000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59457000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61435000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61145000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and marketable securities and issuers of investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the United States, and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse effect on our financial position, liquidity or results of operations. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">88%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts Specialty Distribution Services, Inc. and its affiliates, or Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">67%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable and McKesson Corporation and its affiliates, or McKesson, which accounted for </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">86%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">66%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and IDIS Limited, which accounted for </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We depend on single source suppliers and manufacturers for each of our products, product candidates and their active pharmaceutical ingredients.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001232524-15-000157-index-headers.html	Edgar Link	pending
0001232524-15-000157-index.html	Edgar Link	pending
0001232524-15-000157.txt	Edgar Link	pending
0001232524-15-000157-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jazz-20150930.xml	Edgar Link	completed
jazz-20150930.xsd	Edgar Link	pending
jazz-20150930_cal.xml	Edgar Link	unprocessable
jazz-20150930_def.xml	Edgar Link	unprocessable
jazz-20150930_lab.xml	Edgar Link	unprocessable
jazz-20150930_pre.xml	Edgar Link	unprocessable
jazz2015q3doc.htm	Edgar Link	pending
jazzq32015ex101.htm	Edgar Link	pending
jazzq32015ex311.htm	Edgar Link	pending
jazzq32015ex312.htm	Edgar Link	pending
jazzq32015ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

2015 Q4 Form 10-Q Financial Statement

#000123252415000157 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ Jazz Pharmaceuticals PLC Stock $jazz

2015 Q4 Form 10-Q Financial Statement

#000123252415000157 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz